You will need to analyze, synthesize, and evaluate the article’s importance to our understanding of current trends in executive development and workplace dynamics. DO NOT SUMMARIZE! Use the readings form the class (i.e., text, PDFs, and videos) to help provide a vocabulary for understanding executive development.
You will be assessed on your ability to clearly identify the problems of the case, provide clear solutions, and generally apply the material from this course to understanding and solving issues in executive development and management more generally.
The purpose of the response is to demonstrate your ability to explain and apply the topics of this course (readings, videos, etc.). Therefore, if all you say is something to the effect of, “I agree!” “She has a point” or “I don’t agree” and fail to provide any further explanation or context, well, then you can expect NOT to get any points for that type of response…sorry, not sorry.
ble time of previous SDX intake SDX concentration on day 0 and on day 7, the back estimation method indicated a means of 29 days prior to enrolment and drug administration in the study(range 5-69 days; 90% CI), the most likely time for previous SDX intake. Majority of the patients i.e. 23 (46.9%) showed previous SDX intake estimated time of more than 28 days. Residual antimalarial in different age groups The patient samples were divided in three groups on the basis of age viz. ‘ 6 month to <5yrs, ‘5 yrs to <15yrs and ’15yrs to observe the effect of irrational practices in different age groups. Since, 70 patients had residual antimalarials on day 0, the age wise residual antimalarial drugs were 8.6%, 31.4% and 60.0% respectively. indicating the maximum intake in adult patients. CRF information & residual antimalarial A total of 295 patients were analysed for the previous drug intakes using case record form (CRF) information; 21.1% patients did not took drug, 75.4% patients were not aware about previous intake and 3.5% of the patients were in category where information was not recorded. However, blood samples were analysed on day 0 by HPLC, 24.2 % patients had residual antimalarial. Rarasite density with residual CQ: Parasitemia was compared between patients had residual antimalarials (n=27) on day 0; 1056 to 78240 asexual parasites/”l (mean ”SD: 20394”19735 asexual parasites/”l) and with patients not having residual CQ on day 0 (n=262), that is, 616 to 99290 asexual parasites/”l (mean” SD: 23687”25835 asexual parasites/”l). Low level of residual CQ in those samples which had higher parasite density per microliter of blood and vice versa. Parasite density with residual SDX:>GET ANSWER